Yukon Medical, a Research Triangle Park, North Carolina based medical device firm, has received a grant of $244,479.25 for its SmartMix delivery platform, under the 2010 Qualifying Therapeutic Discovery Project (QTDP).

Assisted by its accounting firm Langdon & Co of Garner, the grant application submitted by Yukon resulted in this grant in furtherance of its ‘development of a safe, effective and efficient method for reconstitution of lyophilized drugs and biologics.’

The SmartMix delivery platform utilises standard glass vials to minimise the potential for complications that can arise from incorporating a new delivery system while reducing the steps to prepare and deliver medication, Yukon Medical said.

The QTDP program was created by the US Patient Protection and Affordable Care Act of 2010 and oversaw the allocation of $1bn in tax credits and grants for the 2009 and 2010.

The IRS, in conjunction with the Department of Health and Human Services, approved applications for projects that showed significant potential to produce new and cost-saving therapies, support jobs and increase US competitiveness.